East Idaho News on MSN

‘What true humanity is supposed to be.’ Veteran receives free furnace from local company

Eastern Idaho local Frank Perry served in the United States Army during the Vietnam War after he was drafted at 18.

10 reasons why you can't stop coughing and what to do about it

A chronic cough can be due to many things from asthma to post-COVID-19. Here's how to figure out why you can't stop coughing ...

The symptoms of Chronic obstructive pulmonary disease include coughing, shortness of breath, and fatigue

If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...
The American Journal of Managed Care

Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD

Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...

GSK's three-drug inhaler wins U.S. nod for use in asthma patients

GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once to be ...
Medscape

FDA Gives Nod to Nerandomilast for Severe Lung Disease

Nerandomilast, marketed as Jascayd by its manufacturer Boehringer Ingelheim, is the first therapy approved in more than 10 ...
Managed Healthcare Executive

FDA Approves a New Option for Idiopathic Pulmonary Fibrosis

Jascayd targets the enzyme PDE4B, which plays a role in the inflammatory process. The new therapy is able to affect both fibrosis and the immune system. It will be available in the next few weeks.
Healio

FDA approves nerandomilast for idiopathic pulmonary fibrosis

The FDA granted approval to nerandomilast, now Jascayd, for treating adults with idiopathic pulmonary fibrosis, marking the first treatment approved for this indication in more than 10 years, ...